首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1623414

2024 年至 2031 年女性健康市場規模（按應用、分銷管道和地區劃分）

Women's Health Market Size By Application (Contraceptives, Osteoporosis, Menopause), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), And Region for 2024-2031

出版日期: 2024年08月14日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年至 2031 年女性健康市場評估

針對女性特定需求的個人化醫療保健解決方案的需求不斷增長，推動了女性醫療保健市場的成長。據 Verified Market Research 分析師稱，女性健康市場規模預計將從 2023 年的約 431.5 億美元下降到 2031 年預測期內的 652.3 億美元。

技術進步和對婦女賦權的重新關注正在推動全球婦女健康醫藥市場向前發展。需求激增將推動市場在 2024 年至 2031 年期間以 5.3% 的複合年增長率成長。

女性健康市場定義/概述

婦女健康是醫學和醫療保健的一個分支，重點是女性一生中的生理、心理和社會需求。它涵蓋了廣泛的主題，包括生殖健康、孕產婦健康、婦科疾病、心理健康和一般健康。婦女健康是指提供適當、全面的護理，考慮到生物、文化和社會方面，並根據婦女的特定需求量身定制。

它還包括預防措施，如頻繁篩檢、接種疫苗和健康生活方式選擇的教育，以及對女性影響較大或不同的疾病的診斷和治療。透過全面解決女性健康問題，醫療保健提供者可以幫助女性過上更健康、更有意義的生活，同時最大限度地減少醫療保健取得和結果方面的不平等。

推動女性健康市場發展的因素有哪些？

女性對預防保健的認識以及早期疾病檢測的重要性推動了對女性保健服務和產品的需求。醫療技術的進步，包括更好的診斷、微創手術和新的治療方法，正在擴大女性保健解決方案的範圍並改善患者的治療效果。隨著女性年齡的增長，她們更容易患上與年齡相關的健康問題，如骨質疏鬆症、更年期和婦科癌症。女性心臟病、糖尿病和癌症等慢性病的流行推動了對針對女性獨特健康需求的專門醫療服務、診斷和治療方案的需求。

女性市場受到政府措施的推動，例如宣傳活動、研發資金以及醫療改革。文化態度的變化也促使了婦女健康問題的發展，例如需要淡化某些健康狀況的識別性，以及在獲得醫療保健方面性別平等的重要性日益增加。

影響女性健康市場面臨哪些課題？

女性健康問題，尤其是與生殖、心理和性健康相關的問題，經常受到歧視，導致報告不足、診斷延誤以及獲得適當醫療保健服務的機會有限。在獲得醫療保健、治療選擇和研究資金方面的性別不平等導致了女性健康狀況不佳。由於社會經濟地位、地理位置和文化規範，婦女常常面臨獲得優質醫療保健的障礙。婦女健康教育和意識較低，尤其是在邊緣化社區，阻礙了子宮頸癌和乳癌等常見健康問題的早期發現、預防和治療，以及產婦死亡率。

女性在臨床試驗中的代表性不足，導致缺乏針對女性的醫療幹預和治療的有效性和安全性的數據。女性的健康需求是多方面的、複雜的，需要採取包括預防、早期發現和根據每個人的需求量身定制的綜合治療策略在內的整體方法，這阻礙了市場擴張。

概述
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 其他亞太地區
拉丁美洲
- 陶氏化學巴西公司
- 阿根廷
- 其他拉丁美洲國家
中東和非洲
- 阿拉伯聯合大公國
- 沙烏地阿拉伯
- 南非
- 其他中東和非洲地區

第 8 章全球女性健康市場的競爭格局

概述
各公司的市場排名
重大進展
公司地理分佈
公司依行業分佈
ACE 矩陣

第9章公司簡介

Siemens
Hologic Inc.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Abbott
BD
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Koninklijke Philips N.V.
NeuroLogica Corp.
Shimadzu Medical pvt. Ltd.

第 10 章重大進展

產品發佈/開發
合併和收購
業務擴展
夥伴關係和合作關係

第 11 章經過驗證的市場情報

動態資料視覺化

簡介目錄

Product Code: 22170

Women's Health Market Valuation - 2024-2031

The growing desire for individualized healthcare solutions targeted to women's specific needs is fueling the growth of the Women's Health Market. According to the analyst from Verified Market Research, the Women's Health Market is estimated to reach a valuation of USD 65.23 Billion over the forecast period 2031, subjugating around USD 43.15 Billion in 2023.

Technological advancements and a renewed emphasis on women's empowerment are moving the worldwide Women's Health Market forward. This surge in demand enables the market to grow at aCAGR of 5.3% from 2024 to 2031.

Women's Health Market Definition/ Overview

Women's health is the field of medicine and healthcare that focuses on the physiological, psychological, and social requirements of women throughout their lives. It covers a wide range of topics, including reproductive health, maternal health, gynecological concerns, mental health, and general well-being. Women's health is to provide appropriate and comprehensive care customized to their unique needs, taking into account biological, cultural, and social aspects.

Furthermore, this includes preventive efforts including frequent screenings, vaccines, and education about healthy lifestyle choices, as well as the diagnosis and treatment of illnesses that affect women disproportionately or differently than men. By treating women's health holistically, healthcare practitioners may help women live healthier and more meaningful lives while minimizing inequities in healthcare access and outcomes.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Which Drivers Are Encouraging the Women's Health Market?

The demand for women's health services and products is driven by women's awareness of preventive healthcare and the importance of early detection of diseases. Advances in medical technology, including better diagnostics, minimally invasive surgery, and new treatment options, are broadening the range of women's healthcare solutions and improving patient outcomes. As women age, they are more likely to experience age-related health problems, including osteoporosis and menopause-related symptoms, as well as gynecological cancers. The prevalence of chronic diseases, such as heart disease, diabetes, and cancer, among women is increasing the need for specialized health services, diagnostics, and treatment options that are tailored to women's unique health needs.

The women's market is being driven by government initiatives, including awareness campaigns, research and development funding, and healthcare reforms. Women's health issues are also being driven by changing cultural attitudes, such as the need to destigmatize certain health conditions and the increased importance of gender equality in access to healthcare.

What are the Challenges in Impacting the Women's Health Market?

Women's health issues, especially those related to reproductive, mental, and sexual health, are often stigmatized, leading to underreporting, delayed diagnosis, and limited access to adequate healthcare services. Gender inequalities in healthcare access and treatment options, as well as research funding, lead to poor health outcomes for women. Women often face barriers to quality healthcare due to socio-economic status, geographical location, and cultural norms. Poor education and awareness about women's health, especially in marginalized communities, prevent early detection, prevention, and treatment for common health conditions, such as cervical cancer and breast cancer, as well as maternal mortality, and hence limit the market growth.

Women are not adequately represented in clinical trials, which leads to a lack of data on the effectiveness and safety of medical interventions and treatments for women. Women's health needs are multifaceted and complex, requiring a holistic approach that includes prevention, early detection, and comprehensive treatment strategies that are tailored to each individual's needs, inhibiting market expansion.

Category-Wise Acumens

How do Hospital Pharmacies help in the Growth of the Women's Health Market?

According to VMR analysis, the hospital pharmacies segment is estimated to dominate the market during the forecast period due to a wide extend of drugs utilized within the treatment of women's well-being conditions, including contraceptives, hormone substitution treatments, richness drugs, and medicines for gynecological and obstetric clutters. By guaranteeing convenient get to these medicines, hospital stores contribute to the successful administration of women's well-being issues. Drug specialists in hospitals give important quiet instruction and counseling administrations to ladies getting treatment for different well-being conditions. They offer data almost medicine utilization, potential side impacts, adherence techniques, and way-of-life adjustments to advance ideal well-being results. Patient education enables ladies to form educated choices almost their wellbeing and treatment alternatives.

Hospital pharmacies collaborate closely with healthcare suppliers, including doctors, medical attendants, and other individuals of the healthcare group, to provide comprehensive and facilitated care to ladies. Drug specialists take an interest in multidisciplinary rounds, pharmaceutical treatment administration, and treatment arranging sessions to guarantee that women's well-being needs are tended to comprehensively and in arrangement with the best hones. Hospital stores offer forte compounding administrations to plan customized medications tailored to the special needs of personal patients. This will be especially advantageous in women's well-being, where personalized medicine details are required for conditions such as hormone treatment, ripeness medications, and pre-birth care.

Also, hospital pharmacies serve as fundamental columns of back for women's well-being by giving get to medicines, conveying patient-centered care, advancing pharmaceutical security and adherence, and contributing to the progression of healthcare through investigation and development. Their necessary part within the healthcare biological system makes a difference drive the development and advancement of women's well-being results.

Which Factors are Influencing the Growth in the Contraceptives Market in the Women's Health Market?

The contraceptives segment is estimated to exhibit the highest growth within the Women's Health Market during the forecast period. Growing awareness among women and couples about reproductive health, family planning, and the importance of contraceptives is a major driver of segment growth. Educational campaigns, initiatives by health organizations, and government programs that focus on contraceptive methods and their benefits empower women to make informed choices about their reproductive health.

The increasing participation of women in the workforce across industries and geographies has led to changes in lifestyles and social norms. With increasing emphasis on career advancement, delaying marriage, and higher education, women are increasingly looking for contraceptive solutions that offer convenience, effectiveness, and minimal side effects. This need for flexible, long-lasting contraceptive methods that fit a fast-paced lifestyle has increased demand among working women for hormonal implants, intrauterine devices (IUDs), and contraceptive patches.

Furthermore, government-led initiatives and public health programs to promote family planning, reduce unintended pregnancies, and address maternal and child health play an important role in promoting contraceptive usage. Many governments around the world implement family planning programs that provide subsidized or free contraceptive services, counseling, and access to contraceptives through health services and community-based outreach activities.

Women's Health Market

Report Methodology

Country/Region-wise Acumens

Which Region has the Most Potential for Growth in the Women's Health Market?

The Asia-Pacific region is estimated to grow at the highest CAGR within the forecast period due to a huge and quickly developing population, with a critical extent being ladies. As healthcare foundation moves forward and disposable incomes rise in nations over the region, there's a developing request for women's well-being administrations and items. Financial advancement in nations like China, India, Japan, South Korea, and Australia has driven to expand healthcare investing. This incorporates ventures in women's health clinics, clinics, symptomatic offices, and pharmaceuticals, driving advertise growth.

There's a developing mindfulness of women's well-being issues within the Asia-Pacific region, driven by instruction, urbanization, and expanded get to data through the web and social media. This has driven more prominent requests for preventive screenings, contraceptives, maternal healthcare administrations, and medicines for conditions such as breast cancer and cervical cancer. Numerous governments within the Asia-Pacific locale are contributing to the healthcare framework and actualizing open well-being programs centered on women's well-being. These activities point to moving forward maternal and child well-being, decreasing maternal mortality rates, increment get to family arranging administrations, and addressing gender-based well-being incongruities.

Furthermore, Advancements in therapeutic innovation and telemedicine are making healthcare more open to ladies in inaccessible and rustic ranges of the Asia-Pacific region. Portable well-being apps, teleconsultation administrations, and inaccessible monitoring devices are making a difference in bridging the crevice between urban and rustic healthcare administrations. This combination of statistical patterns, financial development, making strides in healthcare foundation, and raising awareness of women's well-being issues makes the Asia-Pacific region a key range for development within the women's well-being advertise.

Which Regions Dominate in the Women's Health Market?

North America is estimated to dominate the Women's Health Market during the forecast period due to sophisticated healthcare infrastructure, rising awareness of women's health concerns, and high healthcare spending. Countries such as the United States and Canada have well-developed healthcare systems that provide improved diagnostic and treatment options for a variety of women's health issues.

Furthermore, Europe also holds a substantial market share of the Women's Health Market, owing to factors such as government measures to improve women's health, rising incidence of chronic illnesses among women, and increased knowledge of preventative healthcare. Countries such as Germany, the United Kingdom, and France have strong healthcare systems and research institutions focused on women's health. These regions lead the Women's Health Market because of sophisticated healthcare infrastructure, government efforts, and rising prevalence of women's health issues, and growing awareness about preventive healthcare among women.

Competitive Landscape

The competitive landscape in the Women's Health Market is dynamic and evolving, driven by changing customer preferences, technological advancements, and market dynamics. Providers continue to innovate and differentiate their offerings to stay competitive and capture market share in this rapidly growing industry.

Some of the prominent players operating in the Women's Health Market include:

Siemens, Hologic Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Abbott, BD, Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Koninklijke Philips N.V., NeuroLogica Corp., Shimadzu Medical Pvt. Ltd., GENERAL ELECTRIC, Quest Diagnostics Incorporated, Sysmex India Pvt. Ltd., Hitachi Ltd., Canon Inc., FUJIFILM Holdings Corporation

Latest Developments

In October 2023, The American College of Obstetricians and Gynecologists (ACOG) released new guidelines on contraceptive care, emphasizing a patient-centered approach and including long-acting reversible contraceptives (LARCs) as the first-line options for most individuals.

In September 2023, The FDA approved a new at-home test for chlamydia and gonorrhea called "Everlywell Self-Collection STD Test," aiming to increase access to convenient and discreet testing options.

In August 2023, Pfizer announced a collaboration with Merck to develop and commercialize an mRNA vaccine against human papillomavirus (HPV), which can cause cervical cancer and other cancers.

1 INTRODUCTION OF GLOBAL WOMEN'S HEALTH MARKET

1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Assumptions
1.5 Limitations

2 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

2.1 Data Mining
2.2 Data Triangulation
2.3 Bottom-Up Approach
2.4 Top-Down Approach
2.5 Research Flow
2.6 Key Insights from Industry Experts
2.7 Data Sources

3 EXECUTIVE SUMMARY

3.1 Market Overview
3.2 Ecology Mapping
3.3 Absolute Market Opportunity
3.4 Market Attractiveness
3.5 Global Women's Health Market Geographical Analysis (CAGR %)
3.6 Global Women's Health Market, By Application (USD Million)
3.7 Global Women's Health Market, By Distribution Channel (USD Million)
3.8 Future Market Opportunities
3.9 Global Market Split
3.10 Product Life Line

4 GLOBAL WOMEN'S HEALTH MARKET OUTLOOK

4.1 Global Women's Health Evolution
4.2 Drivers
- 4.2.1 Driver 1
- 4.2.2 Driver 2
4.3 Restraints
- 4.3.1 Restraint 1
- 4.3.2 Restraint 2
4.4 Opportunities
- 4.4.1 Opportunity 1
- 4.4.2 Opportunity 2
4.5 Porters Five Force Model
4.6 Value Chain Analysis
4.7 Pricing Analysis
4.8 Macroeconomic Analysis

5 GLOBAL WOMEN'S HEALTH MARKET, BY APPLICATION

5.1 Overview
5.2 Contraceptives
5.3 Osteoporosis
5.4 Menopause
5.5 Others

6 GLOBAL WOMEN'S HEALTH MARKET, BY DISTRIBUTION CHANNEL

6.1 Overview
6.2 Hospitals Pharmacies
6.3 Retail Pharmacies
6.4 Online Pharmacies

7 GLOBAL WOMEN'S HEALTH MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Dow Chemical Company Brazil
- 7.5.2 Argentina
- 7.5.3 Rest of Latin America
7.6 Middle-East and Africa
- 7.6.1 UAE
- 7.6.2 Saudi Arabia
- 7.6.3 South Africa
- 7.6.4 Rest of Middle-East and Africa

8 GLOBAL WOMEN'S HEALTH MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Developments
8.4 Company Regional Footprint
8.5 Company Industry Footprint
8.6 ACE Matrix

9 COMPANY PROFILES

9.1 Siemens
- 9.1.1 Company Overview
- 9.1.2 Company Insights
- 9.1.3 Product Benchmarking
- 9.1.4 Key Development
- 9.1.5 Winning Imperatives
- 9.1.6 Current Focus & Strategies
- 9.1.7 Threat from Competition
- 9.1.8 SWOT Analysis
9.2 Hologic Inc.
- 9.2.1 Company Overview
- 9.2.2 Company Insights
- 9.2.3 Product Benchmarking
- 9.2.4 Key Development
- 9.2.5 Winning Imperatives
- 9.2.6 Current Focus & Strategies
- 9.2.7 Threat from Competition
- 9.2.8 SWOT Analysis
9.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- 9.3.1 Company Overview
- 9.3.2 Company Insights
- 9.3.3 Product Benchmarking
- 9.3.4 Key Development
- 9.3.5 Winning Imperatives
- 9.3.6 Current Focus & Strategies
- 9.3.7 Threat from Competition
- 9.3.8 SWOT Analysis
9.4 Abbott
- 9.4.1 Company Overview
- 9.4.2 Company Insights
- 9.4.3 Product Benchmarking
- 9.4.4 Key Development
- 9.4.5 Winning Imperatives
- 9.4.6 Current Focus & Strategies
- 9.4.7 Threat from Competition
- 9.4.8 SWOT Analysis
9.5 BD
- 9.5.1 Company Overview
- 9.5.2 Company Insights
- 9.5.3 Product Benchmarking
- 9.5.4 Key Development
- 9.5.5 Winning Imperatives
- 9.5.6 Current Focus & Strategies
- 9.5.7 Threat from Competition
- 9.5.8 SWOT Analysis
9.6 F. Hoffmann-La Roche Ltd
- 9.6.1 Company Overview
- 9.6.2 Company Insights
- 9.6.3 Product Benchmarking
- 9.6.4 Key Development
- 9.6.5 Winning Imperatives
- 9.6.6 Current Focus & Strategies
- 9.6.7 Threat from Competition
- 9.6.8 SWOT Analysis
9.7 Thermo Fisher Scientific Inc.
- 9.7.1 Company Overview
- 9.7.2 Company Insights
- 9.7.3 Product Benchmarking
- 9.7.4 Key Development
- 9.7.5 Winning Imperatives
- 9.7.6 Current Focus & Strategies
- 9.7.7 Threat from Competition
- 9.7.8 SWOT Analysis
9.8 Koninklijke Philips N.V.
- 9.8.1 Company Overview
- 9.8.2 Company Insights
- 9.8.3 Product Benchmarking
- 9.8.4 Key Development
- 9.8.5 Winning Imperatives
- 9.8.6 Current Focus & Strategies
- 9.8.7 Threat from Competition
- 9.8.8 SWOT Analysis
9.9 NeuroLogica Corp.
- 9.9.1 Company Overview
- 9.9.2 Company Insights
- 9.9.3 Product Benchmarking
- 9.9.4 Key Development
- 9.9.5 Winning Imperatives
- 9.9.6 Current Focus & Strategies
- 9.9.7 Threat from Competition
- 9.9.8 SWOT Analysis
9.10 Shimadzu Medical pvt. Ltd.
- 9.10.1 Company Overview
- 9.10.2 Company Insights
- 9.10.3 Product Benchmarking
- 9.10.4 Key Development
- 9.10.5 Winning Imperatives
- 9.10.6 Current Focus & Strategies
- 9.10.7 Threat from Competition
- 9.10.8 SWOT Analysis